내시경 검사 분야 AI 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 구성요소별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

AI In Endoscopy Market Summary

The global AI in endoscopy market size was valued at USD 2.93 billion in 2024 and is projected to reach USD 19.53 billion by 2033, growing at a CAGR of 26.83% from 2026 to 2033. increasing global burden of gastrointestinal diseases, including colorectal cancer and inflammatory bowel disease and a significant shift toward minimally invasive endoscopic procedures are significant factors contributing to market growth.

Additionally, rapid advancements in artificial intelligence, particularly in machine learning and computer vision, are driving innovation in the AI endoscopy market. The increasing global burden of gastrointestinal diseases, including colorectal cancer and inflammatory bowel disease, is a primary driver of AI in endoscopy market. For instance, according to the American Cancer Society estimates, in 2024, around 13,920 new small intestine cancer cases were diagnosed in the U.S., and 2,060 individuals died due to small intestine cancer. As the prevalence of small intestine cancer rises globally, there is a growing need for effective diagnostic and treatment procedures. Capsule endoscopy plays a crucial role in offering minimally invasive options to accurately diagnose, stage, and treat various forms of cancer.

Similarly, according to the World Cancer Research Fund, approximately 1.93 million new cases of colorectal cancer were reported globally in 2022, making it one of the most prevalent malignancies. The World Health Organization further emphasizes that regions such as Europe, Australia, and New Zealand exhibit the highest incidence rates, largely due to lifestyle factors, diet, and aging populations.

Global AI In Endoscopy Market Report Segmentation

This report forecasts, revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented global AI in endoscopy market report based on component, type, application, end use, and region.

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• CADe (Computer-Aided Detection)
• CADx (Computer-Aided Diagnosis)
• Component Outlook (Revenue, USD Million, 2021 - 2033)
• AI-enabled devices
• AI Software and Platforms
• Services
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Gastrointestinal Endoscopy
• Bronchoscopy
• Urological Endoscopy
• Capsule Endoscopy
• Gynecological Endoscopy
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers/Specialty clinics
• Diagnostic imaging centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Type Segment
  • 1.2.2. Component Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. AI in Endoscopy Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. AI in Endoscopy Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape

Chapter 4. AI in Endoscopy Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global AI in Endoscopy Market Type Movement Analysis
• 4.3. Global AI in Endoscopy Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. CADe (Computer-Aided Detection)
  • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.5. CADx (Computer-Aided Diagnosis)
  • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. AI in Endoscopy Market: Component Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global AI in Endoscopy Market Component Movement Analysis
• 5.3. Global AI in Endoscopy Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
• 5.4. AI-enabled Devices
  • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.5. AI Software & Platform
  • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Services
  • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. AI in Endoscopy Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global AI in Endoscopy Market Application Movement Analysis
• 6.3. Global AI in Endoscopy Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Gastrointestinal Endoscopy
  • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.5. Bronchoscopy
  • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Urological Endoscopy
  • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Capsule Endoscopy
  • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. Gynecological Endoscopy
  • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.9. Others
  • 6.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. AI in Endoscopy Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global AI in Endoscopy Market End Use Movement Analysis
• 7.3. Global AI in Endoscopy Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.5. Ambulatory Surgical Centers/Specialty clinics
  • 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.6. Diagnostic Imaging Centers
  • 7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. AI in Endoscopy Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2025 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 8.4. North America
  • 8.4.1. U.S.
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.4.2. Canada
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.4.3. Mexico
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. UK
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.2. Germany
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.3. France
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.4. Italy
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.5. Spain
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.6. Norway
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.8. Denmark
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Regulatory framework
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Japan
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.3. India
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.4. Australia
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.6. Thailand
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Brazil
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7.2. Argentina
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.8. MEA
  • 8.8.1. South Africa
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8.2. Saudi Arabia
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8.3. UAE
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8.4. Kuwait
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Regulatory framework
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2025
• 9.4. Company Profiles/Listing
  • 9.4.1. FUJIFILM Corporation
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Olympus Corporation
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Medtronic
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. MAGENTIQ EYE
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. PENTAX Medical (HOYA Group)
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. JINSHAN Science & Technology (Group) Co., Ltd.
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. BioCam
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Endovision
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. EndoSoft
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. AnX Robotica
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. Provation Software, Inc.
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives
  • 9.4.12. ODIN VISION (ODIN MEDICAL LTD)
    • 9.4.12.1. Company overview
    • 9.4.12.2. Financial performance
    • 9.4.12.3. Product benchmarking
    • 9.4.12.4. Strategic initiatives